|
Sign In to gain access to subscriptions and/or personal tools.
|
Induction of DNA Synthesis in Mouse Liver Following Increases of DNA Adduct Levels Elicited by Very Low Cumulative Doses of the Genotoxic Hepatocarcinogen 7H-dibenzo[c,g]carbazole
Olivier Dorchies
Sanofi-Synthelabo Recherche, Department of Toxicology, 2-8 rue de Rouen, 78440 Porcheville, France, olivier.dorchies@sano fi-synthelabo.com
Odette Perin-Roussel
Institut Curie-Recherche, Centre Universitaire, 91405 Orsay Cedex, France
Olivier Gillardeaux
Sanofi-Synthelabo Recherche, Department of Toxicology, 2-8 rue de Rouen, 78440 Porcheville, France
Joan-Albert Vericat
Sanofi-Synthelabo Recherche, Department of Toxicology, 2-8 rue de Rouen, 78440 Porcheville, France
Nigel Oliver Roome
Sanofi-Synthelabo Recherche, Department of Toxicology, 2-8 rue de Rouen, 78440 Porcheville, France
Annick Prenez
Sanofi-Synthelabo Recherche, Department of Toxicology, 2-8 rue de Rouen, 78440 Porcheville, France
François Perin
Institut Curie-Recherche, Centre Universitaire, 91405 Orsay Cedex, France
The purpose of this work was to investigate the administration of very low but repeated doses of a genotoxic carcinogen and an eventual correlation with cellular DNA synthesis. The compound 7H-dibenzo[c,g]carbazole is a genotoxic carcinogen in the mouse liver and was administered topically at the dose of 13.35 µg per animal every 2 days to give a total of 13 applications. Animals were sacrificed 48 hours after every 2 applications until the 10th treatment, then 48 hours after every treatment. Postulated genotoxic effects such as DNA adduct formation were detected by the 32P-post labeling assay. Liver sections were examined for microscopic changes and DNA synthesis. Results showed an increase of the total DNA adduct level in the liver throughout the study with a slowing down in the level after the sixth application of the compound. This change could correspond to the onset of DNA synthesis and to the moderate hepatocellular apoptosis which was observed. The DNA synthesis, which was considered to be secondary to the cytotoxicity induced by the high level of DNA adducts altering normal cellular activity, could also be the opportunity to fix the DNA adducts into heritable mutations. These results raise the question regarding the risk assessment in humans exposed regularly to very low doses of chemicals in the environment: for non-proliferating tissue, the regular accumulation of DNA adducts could remain silent until a "threshold level" is reached from which stimulation of the DNA synthesis may fix the DNA adducts into heritable mutations, eventually leading to tumors.
Key Words: Dibenzo[c,g]carbazole DNA adducts DNA synthesis mouse liver carcinogenesis risk assessment.
References
- Ames BB, Gold LS ( 1990). Too many rodent carcinogens: Mitogenesis increases, mutagenesis. Science 249: 970—971.[Free Full Text]
- Armstrong EC, Bonser GM (1950). Squamous carcinoma of the forestomach and other lesions in mice following oral administration of 3,4,5,6-dibenzocarbazole. Br J Cancer 2: 203—211.
- Boyland E., Mawson EH (1938). Changes in the livers of mice after administration of 3,4,5,6-dibenzocarbazole. Biochem J 32: 1460—1466.[Web of Science][Medline]
[Order article via Infotrieve]
- Butterworth BE, Conolly RB, Morgan KT (1995). A strategy for establishing mode of action of chemicals carcinogens as a guide for approaches to risk assessment. Cancer Lett 93: 129—146.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Butterworth BE, Loury D., Smith-Oliver T., Cattley RC (1987). The potential role of chemically induced hyperplasia in the carcinogenic activity of the hypolipidemi c carcinogens. Toxicol Ind Health 3(2): 129—149.[Web of Science][Medline]
[Order article via Infotrieve]
- Cayama E., Tsuda H., Sarma DSR, Farber E. (1978). Initiation of chemical carcinogenesi s requires cell proliferation. Nature (London) 278: 60— 62.
- Farber E. (1982). Sequential events in chemical carcinogenesis. In Cancer: A Comprehensive Treatise, Vol 1, 2nd ed, Becker, FF (ed). Plenum, New York, pp 485—506.
- Goldstein LS, Weyand EH, Safe S., Steinberg M., Culp SJ, Gaylor DW, Beland FA, Rodriguez LV (1998). Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars; implications for risk assessment. Environ Health Perspect 106(6): 1325—1330.[Web of Science][Medline]
[Order article via Infotrieve]
- Goldsworthy T., Morgan K., Popp J., Butterworth B. (1991). Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. Chemically induced cell proliferation: implications for risk assessment. Wiley-Liss, New York, pp 253—284.
- Gupta RC (1984). Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 81: 6943—6947.[Abstract/Free Full Text]
- Gupta RC, Reddy MV, Randerath K. (1982). 32 P-postlabeling analysis of nonradioactive aromatic carcinogen-DNA adducts. Carcinogenesis 3: 1081—1092.[Abstract/Free Full Text]
- Hillan KJ, Logan MC, Ferrier RK, Bird GL, Benneth GL, McKay IC, MacSween RN (1996). Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis. J Hepatol 24: 385— 390.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hrusovsky S., Jouvenot M., Vuillermoz C., Heyd B., Chabod P., Mantion G., Miguet JP, Adessi GL (1994). Regeneration of transplanted human liver: Gene expression at the time of graft implantation. C R Seances Soc Biol Fil 188: 245—258.[Medline]
[Order article via Infotrieve]
- IARC: International Agency for Research on Cancer (1972). Certain polycyclic aromatic hydrocarbons and heterocyclic compounds. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man. IARC Science Publications No. 3, IARC, Lyon, pp 260—268.
- Jones HB, Eldridge SR, Butterworth BE, Forster JR (1996). Measures of cell replication in risk/safety assessment of xenobiotic-induced, non genotoxic carcinogenesis. Regul Toxicol Pharmacol 23: 117—127.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Johnson RA, Walseth TF (1979). The enzymaticpreparation of [
-32P]ATP, [ -32P]GTP, [32P]cAMP and [32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res 10: 135—167.[Medline]
[Order article via Infotrieve] - Masuhara M., Yasunaga M., Tanigawa K., Tamura F., Yamashita S., Sakaida I., Okita K. (1996). Expression of hepatocytes growth factor, transforming growth factor alpha, transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology 24: 323—329.[Web of Science][Medline]
[Order article via Infotrieve]
- Meier JR, Warshawsky D. (1994). Comparison of blood protein and target organ DNA and protein binding following topical application of benzo[a]pyrene and 7H-dibenzo[c,g]carbazole to mice. Carcinogenesis 15(10): 2233—2240.[Abstract/Free Full Text]
- Perin F., Dufour M., Mispelter J., Ekert B., Kunneke C., Oesch F., Zajdela F. (1981). Heterocyclic polycyclic aromatic hydrocarbon carcinogenesis: 7H-dibenzo[c,g]carbazole metabolism by microsomal enzymes from mouse and rat liver. Chem-Biol Interact 35: 267—284.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Perin F., Perin-Roussel O., Taras-Valero D., Mouton D., Covelli V., Zajdela F. (1998). Inversion of genetic predisposition to carcinogenesis in liver of two lines of mice selected for resistance (Car-R) or susceptibility (Car-S) to skin carcinogenesis. Cancer Lett 132: 81—90.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Perin F., Valero D., Thybaud-Lambay V., Plessis MJ, Zajdela F. (1988). Organspecific, carcinogenic dibenzo[c,g]carbazole derivatives: Discriminative response in S. typhimurium TA100 mutagenesis modulated by subcellular fractions of mouse liver. Mutat Res 198: 15—26.[Web of Science][Medline]
[Order article via Infotrieve]
- Perin-Roussel O., Barat N., Zajdela F., Perin F. (1997). Tissue specific differences in adduct formation by hepatocarcinogeni c and sarcomageni c derivatives of 7H-dibenzo[c,g]carbazole in mouse parenchymal and nonparenchymal liver cells. Environ Mol Mutagen 29: 346—356.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Perin-Roussel O., Perin F., Barat N., Plessis F., Zajdela F. (1995). Interaction of 7H-dibenzo[c,g]carbazole and its organospeci fic derivatives with hepatic mitochondrial and nuclear DNA in mouse. Environ Mol Mutagen 25: 202— 210.
- Pott F., Roller M. (1997). Current data and questions on the carcinogenicity of solid particles of diesel engine exhaust and other sources. Zentralbl Hyg Umweltmed 200(2—3):223—280.[Web of Science][Medline]
[Order article via Infotrieve]
- Pound AW, McGuire LJ (1978). Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rat. Br J Cancer 37: 585—594.[Web of Science][Medline]
[Order article via Infotrieve]
- Preston-Martin S., Pike MC, Ross RK, Jones PA, Henderson BE (1990). Increased cell division as a cause of human cancer. Cancer Res 50: 7415— 7421.
- Randerath E., Agrawal HP, Weaver JA, Bordelon CB, Randerath K. (1985). 32 P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene. Carcinogenesis 6: 1117—1126.[Abstract/Free Full Text]
- Randerath K., Reddy MV, Disher RM (1986). Age and tissue-related DNA modifications in untreated rats: detection by 32 P-postlabeling assay and possible significance for spontaneous tumor induction and aging. Carcinogenesis 7: 1615—1617.[Abstract/Free Full Text]
- Reddy MV, Gupta RC, Randerath E., Randerath K. (1984). 32 P-Postlabeling test for covalent DNA binding of chemicals in vivo: Application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis 5: 231— 243.[Abstract/Free Full Text]
- Reddy MV, Randerath K. (1986). Nuclease P1-mediated enhancement of sensitivity of 32 P-Postlabeling test for structurally diverse DNA adducts. Carcinogenesis 7: 1543—1551.[Abstract/Free Full Text]
- Renault D., Tombolan F., Brault D., Perin F., Thybaut V. (1998). Comparative mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in MutaTM Mouse liver and skin. Mutat Res 417: 129—140.[Web of Science][Medline]
[Order article via Infotrieve]
- Sellakumar A., Stenbäck F., Rowland J., Shubik P. (1977). Tumor induction by 7H-dibenzo[c,g]carbazole in the respiratory tract of Syrian hamsters. J Toxicol Environ Health, 3: 935—939.[Web of Science][Medline]
[Order article via Infotrieve]
- Szafarz D., Valero D., PerinF., Bornecque C. (1990). Effect of partial hepatectomy on the formation and elimination of 3-methyl-dibenzo[c,g]carbazole-DNA adducts in mouse liver. Biol Cell 68: 91—94.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Talaska G., Reilman R., Schamer M., Hoon Roh J., Xue W., Fremont S., Warshawsky D. (1994). Tissue distribution of DNA adducts of 7H-dibenzo [c,g]carbazole and its derivatives in mice following topical administration. Chem Res Toxicol 7: 374—379.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tombolan F., Renault D., Brault D., Guffory M., Perin F., Thybaut V. (1999). Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of MutaTM Mice treated with 5,9-dimethyldibenz o[c,g]-carbazole. Carcinogenesis 20: 1357—1362.[Abstract/Free Full Text]
- Tombolan F., Renault R., Brault D., Guffroy M., Perin-Roussel O., Perin F., Thybaut V. (1999). Kinetics of induction of DNA adducts, cell proliferation and gene mutations in the liver of MutaTM Mice treated with 5,9-dimethyl[c,g]dibenzocarbazole. Carcinogenesis 20: 125—132.[Abstract/Free Full Text]
- Valero D., Perin F., Plessis MJ, Zajdela F. (1985). Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyldibenzocarbazole-induce d hepatocarcinogenesi s in mice. Cancer Lett 27: 181—197.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Valero D., Perin F., Zajdela F. (1983). Binding of 5,9-dimethyldibenzo[c,g]-carbazole, a potent hepatocarcinogen, to mouse hepatic cytosolic proteins. Carcinogenesis 4: 1333—1340.[Abstract/Free Full Text]
- Warshawsky D. (1992). Environmental sources, carcinogenicity, mutagenicity, metabolism and DNAbinding of nitrogen and sulfur heterocyclic aromatics. Environ Carcinogen Ecotox Rev C10: 1—71.
- Warshawsky D., Talaska G., Jue W., Schneider J. (1996). Comparative carcinogenicity, metabolism, mutagenicity, and DNA binding of 7H-dibenzo[c,g]carbazole and dibenzo [a,j] acridine. Crit Rev Toxicol 26(2): 213—249.[Web of Science][Medline]
[Order article via Infotrieve]
Toxicologic Pathology, Vol. 29, No. 5,
528-534 (2001)
DOI: 10.1080/019262301317226320

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Martin-Burriel, N. O. Roome, O. Dorchies, and A. Prenez
Histopathological and Molecular Changes During Apoptosis Produced by 7H-Dibenzo[c,g]-Carbazole in Mouse Liver
Toxicol Pathol,
February 1, 2004;
32(2):
202 - 211.
[Abstract]
[PDF]
|
 |
|
|
|